ArticleOncology letters2013

Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment.

Yao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.